Atlas Trials

Safety, Tolerability and Pharmacokinetics of Felbinac Trometamol Eye Drops

Clinical trial NCT05085106 · UNKNOWN

Trial details

NCT number
NCT05085106
Sponsor
Beijing Tongren Hospital
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2020-10-21
Primary completion
2021-10-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.